Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
Public ClinicalTrials.gov record NCT05501041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Quantification of Symptom Relief Following Percutaneous Ablation of the Thyroid
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.
Study identification
- NCT ID
- NCT05501041
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2022
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2028
- Last update posted
- Sep 14, 2025
2022 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Thyroid trials
Other public records listing Thyroid. Sorted by last update posted; newest first. Not a recommendation.
- NCT05733013: A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer Recruiting
- NCT04115514: Treatment of ARDS With Instilled T3 Active, not recruiting
- NCT04615988: Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors Recruiting
- NCT02681328: Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules Active, not recruiting
- NCT04623801: Laser Ablation of Papillary Thyroid Microcarcinoma Active, not recruiting
- NCT02776969: A Gene Hunting Study for Familial Papillary Thyroid Cancer Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05501041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2025 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05501041 live on ClinicalTrials.gov.